Cargando…
Lipid availability determines skeletal progenitor cell fate via SOX9
The avascular nature of cartilage makes it a unique tissue(1–4), but whether and how the absence of nutrient supply regulates chondrogenesis remains unknown. Here, we show that obstruction of vascular invasion during bone healing favours chondrogenic over osteogenic differentiation of skeletal proge...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060079/ https://www.ncbi.nlm.nih.gov/pubmed/32103177 http://dx.doi.org/10.1038/s41586-020-2050-1 |
_version_ | 1783504163250896896 |
---|---|
author | van Gastel, Nick Stegen, Steve Eelen, Guy Schoors, Sandra Carlier, Aurélie Daniëls, Veerle W. Baryawno, Ninib Przybylski, Dariusz Depypere, Maarten Stiers, Pieter-Jan Lambrechts, Dennis Van Looveren, Riet Torrekens, Sophie Sharda, Azeem Agostinis, Patrizia Lambrechts, Diether Maes, Frederik Swinnen, Johan V. Geris, Liesbet Van Oosterwyck, Hans Thienpont, Bernard Carmeliet, Peter Scadden, David T. Carmeliet, Geert |
author_facet | van Gastel, Nick Stegen, Steve Eelen, Guy Schoors, Sandra Carlier, Aurélie Daniëls, Veerle W. Baryawno, Ninib Przybylski, Dariusz Depypere, Maarten Stiers, Pieter-Jan Lambrechts, Dennis Van Looveren, Riet Torrekens, Sophie Sharda, Azeem Agostinis, Patrizia Lambrechts, Diether Maes, Frederik Swinnen, Johan V. Geris, Liesbet Van Oosterwyck, Hans Thienpont, Bernard Carmeliet, Peter Scadden, David T. Carmeliet, Geert |
author_sort | van Gastel, Nick |
collection | PubMed |
description | The avascular nature of cartilage makes it a unique tissue(1–4), but whether and how the absence of nutrient supply regulates chondrogenesis remains unknown. Here, we show that obstruction of vascular invasion during bone healing favours chondrogenic over osteogenic differentiation of skeletal progenitor cells. Unexpectedly, this process is driven by a decreased availability of extracellular lipids. When lipids are scarce, skeletal progenitors activate FoxO transcription factors, which bind to the Sox9 promoter and increase its expression. Besides initiating chondrogenesis, SOX9 acts as a regulator of cellular metabolism by suppressing fatty acid oxidation, and thus adapts the cells to an avascular life. Our results define lipid scarcity as an important determinant of chondrogenic commitment, reveal a role for FoxOs during lipid starvation, and identify SOX9 as a critical metabolic mediator. These data highlight the importance of the nutritional microenvironment in the specification of skeletal cell fate. |
format | Online Article Text |
id | pubmed-7060079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
record_format | MEDLINE/PubMed |
spelling | pubmed-70600792020-08-26 Lipid availability determines skeletal progenitor cell fate via SOX9 van Gastel, Nick Stegen, Steve Eelen, Guy Schoors, Sandra Carlier, Aurélie Daniëls, Veerle W. Baryawno, Ninib Przybylski, Dariusz Depypere, Maarten Stiers, Pieter-Jan Lambrechts, Dennis Van Looveren, Riet Torrekens, Sophie Sharda, Azeem Agostinis, Patrizia Lambrechts, Diether Maes, Frederik Swinnen, Johan V. Geris, Liesbet Van Oosterwyck, Hans Thienpont, Bernard Carmeliet, Peter Scadden, David T. Carmeliet, Geert Nature Article The avascular nature of cartilage makes it a unique tissue(1–4), but whether and how the absence of nutrient supply regulates chondrogenesis remains unknown. Here, we show that obstruction of vascular invasion during bone healing favours chondrogenic over osteogenic differentiation of skeletal progenitor cells. Unexpectedly, this process is driven by a decreased availability of extracellular lipids. When lipids are scarce, skeletal progenitors activate FoxO transcription factors, which bind to the Sox9 promoter and increase its expression. Besides initiating chondrogenesis, SOX9 acts as a regulator of cellular metabolism by suppressing fatty acid oxidation, and thus adapts the cells to an avascular life. Our results define lipid scarcity as an important determinant of chondrogenic commitment, reveal a role for FoxOs during lipid starvation, and identify SOX9 as a critical metabolic mediator. These data highlight the importance of the nutritional microenvironment in the specification of skeletal cell fate. 2020-02-26 2020-03 /pmc/articles/PMC7060079/ /pubmed/32103177 http://dx.doi.org/10.1038/s41586-020-2050-1 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article van Gastel, Nick Stegen, Steve Eelen, Guy Schoors, Sandra Carlier, Aurélie Daniëls, Veerle W. Baryawno, Ninib Przybylski, Dariusz Depypere, Maarten Stiers, Pieter-Jan Lambrechts, Dennis Van Looveren, Riet Torrekens, Sophie Sharda, Azeem Agostinis, Patrizia Lambrechts, Diether Maes, Frederik Swinnen, Johan V. Geris, Liesbet Van Oosterwyck, Hans Thienpont, Bernard Carmeliet, Peter Scadden, David T. Carmeliet, Geert Lipid availability determines skeletal progenitor cell fate via SOX9 |
title | Lipid availability determines skeletal progenitor cell fate via SOX9 |
title_full | Lipid availability determines skeletal progenitor cell fate via SOX9 |
title_fullStr | Lipid availability determines skeletal progenitor cell fate via SOX9 |
title_full_unstemmed | Lipid availability determines skeletal progenitor cell fate via SOX9 |
title_short | Lipid availability determines skeletal progenitor cell fate via SOX9 |
title_sort | lipid availability determines skeletal progenitor cell fate via sox9 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060079/ https://www.ncbi.nlm.nih.gov/pubmed/32103177 http://dx.doi.org/10.1038/s41586-020-2050-1 |
work_keys_str_mv | AT vangastelnick lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT stegensteve lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT eelenguy lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT schoorssandra lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT carlieraurelie lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT danielsveerlew lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT baryawnoninib lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT przybylskidariusz lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT depyperemaarten lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT stierspieterjan lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT lambrechtsdennis lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT vanlooverenriet lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT torrekenssophie lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT shardaazeem lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT agostinispatrizia lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT lambrechtsdiether lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT maesfrederik lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT swinnenjohanv lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT gerisliesbet lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT vanoosterwyckhans lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT thienpontbernard lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT carmelietpeter lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT scaddendavidt lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 AT carmelietgeert lipidavailabilitydeterminesskeletalprogenitorcellfateviasox9 |